NOVARTIS AG (NVSEF)
Clinical trial NCT06751238 updates: 1. completion date: 2032-12-01 → 2031-03-11 2. primary completion date: 2032-11-30 → 2029-10-31
Clinical trial NCT06751238 updates: 1. completion date: 2032-12-01 → 2031-03-11 2. primary completion date: 2032-11-30 → 2029-10-31
📉 **NEGATIVE** • Medium confidence analysis (69%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (20%) **Content type:** Clinical